Comment

Robotic surgical systems market displaying continued growth

Intuitive Surgical is the largest player in the robotic surgical systems market with an estimated global market share of 57%. 

Credit: MAD.vertise via Shutterstock.

Robotic surgical systems market value is projected to reach $3.3bn in 2023 and up to $7.2bn in 2033, with a compound annual growth rate (CAGR) of 15.7%, according to GlobalData, a leading data and analytics company. Intuitive Surgical is the largest player in the robotic surgical systems market with an estimated global market share of 57%. After announcing its Q3 earnings, Intuitive Surgical’s share price dropped by 8% during pre-market trading. 

Intuitive’s $1.74bn revenue fell just short of analysts’ predictions of $1.77bn; however, the values were still promising with a 12% increase from Q3 2022, which was led by Intuitive’s flagship product Davinci and showed a 19% increase in procedures. Another factor that may be contributing to the share drop is increased competition, for example from companies such as CMR Surgical, which just received $165m in funding for its product Versius. Additionally, the Australia-based company Interventional Systems just received FDA approval for the use of the Micromate in the US. 

When a company that dominates the market it operates in, such as Intuitive Surgical, shows signs of decline, this can sometimes be an indication that impacts the entire market. However, in this case, based on the current revenue growth and causes for Intuitive’s share decline, an upward trajectory for robotic surgery is still expected. 

The increasing demand for robotic surgery is brought on by the growing elderly population, as well as a drive towards value-based healthcare, which focuses on improving surgical outcomes for patients. This is providing a push for less-invasive procedure development and for improving the overall technology for robotic surgical systems. Some barriers to the progress of the market are the high cost of the systems and their maintenance, as well as the limited surgeon training with this technology, particularly in developing markets. 

While Intuitive Surgical’s recent decline appears negative, robotic surgery continues to be an increasingly popular alternative to traditional surgery, not only to patients but to companies that are preparing to develop new products. With the major growth and innovation occurring in this market, robotic surgery is sure to have a larger impact on the healthcare sector.

Go to article: Home | No more Dr Google: the rise of symptom checking appsGo to article: Editor's letterGo to article: ContentsGo to article: iDE8Go to article: Formacoat Company InsightGo to article: FormacoatGo to article: Micro SystemsGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: Micro CrystalGo to article: Telemed Company InsightGo to article: TelemedGo to article: In DepthGo to article: No more Dr Google: the rise of symptom checking appsGo to article: Hospital 2040: Will AI regulation safeguard the public, or stifle innovation?Go to article: Reality check needed before healthcare’s AI-centric futureGo to article: Canon Medical integrates sports, AI and diagnostics in new facilityGo to article: HLTH 2023: Viva health technology!Go to article: Robotic surgical systems market displaying continued growthGo to article: Alleima Company InsightGo to article: AlleimaGo to article: On Line ControlsGo to article: mdi ConsultantsGo to article: ListingsGo to article: EventsGo to article: Get ready for the Medical Device Network Excellence Awards Go to article: Buyer's GuidesGo to article: Mimotopes Company InsightGo to article: Next issue